文献速递肺栓塞与肺血管病

混合静脉血氧饱和度在肺动脉高压中比心指数更具预后价值

Mixed Venous Oxygen Saturation Is a Better Prognosticator Than Cardiac Index in Pulmonary Arterial Hypertension.
PubMed 文献 · Chest · 2020-07-03

该回顾性研究纳入158例特发性和遗传性肺动脉高压患者,评估热稀释法心指数(TDCI)与混合静脉血氧饱和度(SvO2)在ESC/ERS风险分组中的一致性及预后价值。结果显示两者一致性差(κ=0.30),仅49%患者风险分组一致;SvO2与生存相关,而TDCI风险分组无显著关联。

要点

  • TDCI与SvO2在ESC/ERS风险分组中一致性差,仅49%患者分组一致
  • SvO2风险分组与生存显著相关,TDCI风险分组无显著关联
  • 校正年龄和性别后,SvO2每升高1%死亡风险降低6%(HR 0.94)

核心结论

  • 在特发性或遗传性肺动脉高压患者中,SvO2测量在预测长期死亡率方面优于TDCI。

研究设计与样本

  • 回顾性研究纳入158例特发性(91%)和遗传性(9%)肺动脉高压患者,平均年龄58±17岁,72%为女性。

主要发现

  • TDCI与SvO2呈中度关联(r=0.50;95%CI 0.37-0.62),风险分组一致性差(加权κ=0.30;95%CI 0.18-0.42),仅49%患者分组一致。
  • 中位随访45个月(IQR 23-105),62例(39%)死亡;Kaplan-Meier分析显示SvO2风险分组影响生存(log rank=0.002),而TDCI风险分组无显著影响(log-rank=0.51)。
  • Cox比例风险模型校正年龄和性别后,SvO2与死亡率相关(每1%变化HR=0.94;95%CI 0.91-0.97;P<.001),TDCI无显著关联。

关键数值与推荐

  • 采用ESC/ERS指南推荐的切点进行TDCI和SvO2风险分组,但两者分组一致性差(κ=0.30)。
  • SvO2每升高1%,死亡风险降低6%(HR 0.94;95%CI 0.91-0.97;P<.001)。

临床怎么用

  • 在特发性或遗传性肺动脉高压风险评估中,应优先关注SvO2而非仅依赖TDCI。
  • ESC/ERS指南中TDCI与SvO2风险分组不一致时,SvO2可能提供更准确的预后信息。

局限性

  • 回顾性研究设计。
  • 样本仅限特发性和遗传性肺动脉高压患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: European Society of Cardiology (ESC) and European Respiratory Society (ERS) guidelines include thermodilution cardiac index (TDCI) and mixed venous oxygen saturation (SvO2) as two of the three hemodynamic determinations used in risk assessment of patients with pulmonary arterial hypertension (PAH). SvO2 may be a better measurement than TDCI to assess prognosis in patients with either idiopathic or heritable PAH. RESEARCH QUESTION: What is the concordance between TDCI and SvO2 ESC/ERS risk group allocation and their prognostic value in patients with PAH? STUDY DESIGN AND METHODS: In this retrospective study, we assessed the correlation between SvO2 and TDCI in patients with idiopathic and heritable PAH. We determined concordance in the ESC/ERS risk group allocation and association with survival, both at baseline and follow-up. RESULTS: A total of 158 patients (mean age, 58 ± 17 years; 72% women) with idiopathic (91%) and heritable (9%) PAH were included. There was moderate association between TDCI and SvO2 (r = 0.50; 95% CI, 0.37-0.62). Weighted kappa revealed a fair agreement between TDCI and SvO2 (κ = 0.30; 95% CI, 0.18-0.42), with concordance in risk group allocation in 49% of patients. During a median follow-up of 45 months (interquartile range, 23-105), 62 patients (39%) died. Using Kaplan-Meier analysis, survival was impacted by the SvO2 (log rank = 0.002) but not by the TDCI risk group allocation (log-rank = 0.51). Using the Cox proportional hazard model, adjusted for age and sex, SvO2 (but not TDCI) was associated with mortality (hazard ratio per 1% change, 0.94; 95% CI, 0.91-0.97; P < .001). INTERPRETATION: When using the cutoffs proposed by the ESC/ERS guidelines, we noted poor concordance in risk score allocation between TDCI and SvO2. In patients with idiopathic or heritable PAH, SvO2 measurements are superior to TDCI in predicting long-term mortality.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Khirfan G, Almoushref A, Naal T, et al. Mixed Venous Oxygen Saturation Is a Better Prognosticator Than Cardiac Index in Pulmonary Arterial Hypertension. Chest. 2020. PMID: 32629034. doi:10.1016/j.chest.2020.06.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。